UTHR - United Therapeutics GAAP EPS of $5.38 beats by $0.34 revenue of $609.4M beats by $23.58M
2023-11-01 06:04:01 ET
More on United Therapeutics
- United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat
- United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision
- United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth More Than Justified
- Second person to get pig heart transplant dies
- United Therapeutics Q3 2023 Earnings Preview
For further details see:
United Therapeutics GAAP EPS of $5.38 beats by $0.34, revenue of $609.4M beats by $23.58M